What is Geno Technology?
Operating under the G-Biosciences brand, Geno Technology is a specialized biotechnology manufacturer headquartered in St. Louis, Missouri. The firm serves as a critical supplier to the research industry, providing an extensive portfolio of protein research products, bioassays, and molecular biology tools. Their market position is defined by a commitment to high-quality standards, competitive pricing models, and a reliable supply chain that supports complex genomic DNA purification and cell toxicity assay requirements. By maintaining a focus on the intersection of technical precision and customer-centric service, the company has established itself as a foundational partner for academic and commercial research laboratories worldwide.
How much funding has Geno Technology raised?
Geno Technology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Geno Technology
PPP
Public-Private Partnership
What's next for Geno Technology?
With the successful closure of this late-stage financing, Geno Technology is poised to transition into a phase of aggressive market scaling and product diversification. The strategic allocation of this capital will likely focus on enhancing manufacturing throughput and expanding the company's R&D pipeline to address emerging trends in molecular biology. As the firm continues to navigate the complexities of the life sciences supply chain, this infusion of resources provides the necessary liquidity to pursue potential inorganic growth opportunities or further optimize its existing distribution networks. Stakeholders can expect a continued emphasis on operational excellence as the company solidifies its role as a premier provider of essential research reagents and analytical tools.
See full Geno Technology company page
